Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Cervical cancer: does the western world have a benefit?

Gemma Kenter • 2 Jun 2019
ASCO 2019
Cervical Cancer Gynecological Cancer

Gemma Kenter, MD, PhD, of the Amsterdam Centre for Oncological Gynaecology, Amsterdam, The Netherlands, tells us about a trial she was involved with that investigated the use of neoadjuvant chemotherapy and radical surgery to standard chemotherapy and radiation for the treatment of cervical cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Gemma Kenter

DIRVA: intratumorally injected durvalumab for cervical cancer
1:30
DIRVA: intratumorally injected durvalumab for cervical cancer
Gemma Kenter • 2 Jun 2019
HPV vaccinations
2:03
HPV vaccinations
Gemma Kenter • 2 Jun 2019

Related Videos

The future of antibody-drug conjugates in endometrial cancer
1:10
The future of antibody-drug conjugates in endometrial cancer
Linda Mileshkin • 30 May 2026
B7-H4-directed ADC in endometrial versus ovarian cancer
0:43
B7-H4-directed ADC in endometrial versus ovarian cancer
Linda Mileshkin • 30 May 2026
Barriers to cervical cancer screening among rural women in India
0:54
Barriers to cervical cancer screening among rural women in India
Shailendra Dandge • 31 May 2026
A community-based model for cervical cancer screening uptake in rural India
8:39
A community-based model for cervical cancer screening uptake in rural India
Shailendra Dandge • 31 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals